Cargando…
Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery
Open-access drug discovery provides a substantial resource for diseases primarily affecting the poor and disadvantaged. The open-access Pathogen Box collection is comprised of compounds with demonstrated biological activity against specific pathogenic organisms. The supply of this resource by the Me...
Autores principales: | Duffy, Sandra, Sykes, Melissa L., Jones, Amy J., Shelper, Todd B., Simpson, Moana, Lang, Rebecca, Poulsen, Sally-Ann, Sleebs, Brad E., Avery, Vicky M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571359/ https://www.ncbi.nlm.nih.gov/pubmed/28674055 http://dx.doi.org/10.1128/AAC.00379-17 |
Ejemplares similares
-
In Vitro Activity of Solithromycin against Bordetella pertussis, an Emerging Respiratory Pathogen
por: Hardy, Dwight J., et al.
Publicado: (2016) -
Minocycline Activity against Unusual Clinically Significant Gram-Negative Pathogens
por: Shortridge, Dee, et al.
Publicado: (2021) -
Biocide Exposure Induces Changes in Susceptibility, Pathogenicity, and Biofilm Formation in Uropathogenic Escherichia coli
por: Henly, E. L., et al.
Publicado: (2019) -
In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014
por: Pfaller, M. A., et al.
Publicado: (2017) -
Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens
por: Landini, Giulia, et al.
Publicado: (2016)